Kathryn M. Haider
A5016200123- Retinopathy of Prematurity Studies
- Ophthalmology and Visual Impairment Studies
- Intraocular Surgery and Lenses
- Glaucoma and retinal disorders
- Neonatal Respiratory Health Research
- Neonatal Health and Biochemistry
- Retinal Diseases and Treatments
- Ophthalmology and Eye Disorders
- Visual perception and processing mechanisms
- Corneal surgery and disorders
- Neonatal and fetal brain pathology
- Renal and related cancers
- Advanced Optical Imaging Technologies
- Migraine and Headache Studies
- Traumatic Ocular and Foreign Body Injuries
- Retinal Imaging and Analysis
- Retinal Development and Disorders
- Vascular Malformations Diagnosis and Treatment
- Genetic and Kidney Cyst Diseases
- Vascular Malformations and Hemangiomas
- Ocular Infections and Treatments
- Soft tissue tumor case studies
- Craniofacial Disorders and Treatments
- Retinal and Macular Surgery
- Biomedical Research and Pathophysiology
Indiana University – Purdue University Indianapolis
2013-2024
Indiana University School of Medicine
2012-2024
Riley Hospital for Children
2014-2023
Indiana University
2014-2022
University School
2020
Ophthalmology Associates (United States)
2017
Hypertension Institute
2015-2016
Midwest Eye Institute
2013-2015
Indiana University Indianapolis
2014
Saint Louis University
2008
Intravitreous bevacizumab (0.25 to 0.625 mg) is increasingly used treat type 1 retinopathy of prematurity (ROP), but there remain concerns about systemic toxicity. A much lower dose may be effective while reducing risk.To find a intravitreous that was than previously for severe ROP, in this study, and could tested future larger studies.Between May 2015 September 2016, 61 premature infants with ROP or both eyes were enrolled masked, multicenter, phase de-escalation study. One eye 10 14...
Intravitreous bevacizumab (0.25 mg to 0.625 mg) is commonly used treat type 1 retinopathy of prematurity (ROP), but there are concerns about systemic toxicity, particularly the risk neurodevelopmental delay. A much lower dose may be effective for ROP while reducing risk. Previously, after testing doses 0.25 0.031 mg, as low were found in small cohorts infants.To find lowest intravitreous severe ROP.Between April 2017 and May 2019, 59 premature infants with or both eyes enrolled a masked,...
<h3>Importance</h3> Cataract is an important cause of visual impairment in children. Data from a large pediatric cataract surgery registry can provide real-world estimates outcomes and the 5-year cumulative incidence adverse events. <h3>Objective</h3> To assess acuity (VA), complications additional eye operations, refractive error 5 years after lensectomy among children younger than 13 years. <h3>Design, Setting, Participants</h3> This prospective cohort study used data Pediatric Eye Disease...
<div class="ftSection"><span class="ftInlineSubsectionTitle">Purpose:</span><p>The purpose of this study was to determine variations in central corneal thickness (CCT) preschool and school-aged African American white children. Secondary aims were assess possible correlations between CCT measurements gender, axial length, intraocular pressure (IOP), family history glaucoma, or prematurity.</p></div><div...
<h3>Importance</h3> Previous studies of<i>myo</i>-inositol in preterm infants with respiratory distress found reduced severity of retinopathy prematurity (ROP) and less frequent ROP, death, intraventricular hemorrhage. However, no large trials have tested its efficacy or safety. <h3>Objective</h3> To test the adverse events to reduce type 1 ROP among younger than 28 weeks' gestational age. <h3>Design, Setting, Participants</h3> Randomized clinical trial included 638 age enrolled from 18...
Senior-Loken syndrome is a rare genetic disorder that presents with nephronophthisis and retinal degeneration, leading to end-stage renal disease progressive blindness. The most frequent cause of juvenile mutation in the type 1 (NPHP1) gene. NPHP1 encodes protein nephrocystin-1, which functions at transition zone (TZ) primary cilia.We report 9-year-old boy deletion, who bilateral vision decrease cystic disease. Renal function deteriorated require nephrectomy transplant. We performed...
Importance Increased myopic shift was found to be associated with 1 year of overminus spectacle treatment for children intermittent exotropia (IXT). Persistence after discontinuing spectacles is unknown. Objective To compare refractive error change over 3 years in IXT originally treated vs nonoverminus spectacles. Design, Setting, and Participants This study an 18-month extension the Trial Overminus Spectacle Therapy Intermittent Exotropia cohort, which previously randomized aged 10 baseline...
Abstract Background Retinopathy of prematurity (ROP) is a disease that affects preterm infants born younger than 30 weeks gestation. The pathophysiology ROP involves an initial vaso-obliterative phase followed by vaso-proliferative leads to progression. use supplemental oxygen during the has been associated with reduced progression, but how this impacts need for treatment unclear. goal study was compare rate laser or intravitreal bevacizumab after implementation new therapy protocol in stage...
<h3>Importance</h3> The Pediatric Eye Disease Investigator Group Cataract Registry provides a multicenter assessment of visual outcomes and complications after lensectomy for traumatic pediatric cataract. <h3>Objective</h3> To report acuity (VA) the cumulative proportion with strabismus, glaucoma, other ocular by 15 months cataract among children younger than 13 years at time surgery. <h3>Design, Setting, Participants</h3> From June 18, 2012, to July 8, 2015, 1266 eyes 994 from 33 eye care...